60 related articles for article (PubMed ID: 19194194)
21. Two Swedish founder MSH6 mutations, one nonsense and one missense, conferring high cumulative risk of Lynch syndrome.
Cederquist K; Emanuelsson M; Wiklund F; Golovleva I; Palmqvist R; Grönberg H
Clin Genet; 2005 Dec; 68(6):533-41. PubMed ID: 16283884
[TBL] [Abstract][Full Text] [Related]
22. Metachronous T-Lymphoblastic Lymphoma and Burkitt Lymphoma in a Child With Constitutional Mismatch Repair Deficiency Syndrome.
Alexander TB; McGee RB; Kaye EC; McCarville MB; Choi JK; Cavender CP; Nichols KE; Sandlund JT
Pediatr Blood Cancer; 2016 Aug; 63(8):1454-6. PubMed ID: 27037742
[TBL] [Abstract][Full Text] [Related]
23. Polymorphisms of DNA repair genes and susceptibility to acute childhood lymphoblastic leukemia.
Scrideli CA; Tone LG
Leuk Res; 2009 Jun; 33(6):745-6. PubMed ID: 19157549
[No Abstract] [Full Text] [Related]
24. MSH6 haploinsufficiency at relapse contributes to the development of thiopurine resistance in pediatric B-lymphoblastic leukemia.
Evensen NA; Madhusoodhan PP; Meyer J; Saliba J; Chowdhury A; Araten DJ; Nersting J; Bhatla T; Vincent TL; Teachey D; Hunger SP; Yang J; Schmiegelow K; Carroll WL
Haematologica; 2018 May; 103(5):830-839. PubMed ID: 29449434
[TBL] [Abstract][Full Text] [Related]
25. Loss of DNA mismatch repair function and cancer predisposition in the mouse: animal models for human hereditary nonpolyposis colorectal cancer.
Edelmann L; Edelmann W
Am J Med Genet C Semin Med Genet; 2004 Aug; 129C(1):91-9. PubMed ID: 15264277
[TBL] [Abstract][Full Text] [Related]
26. [Molecular biology in childhood acute lymphoblastic leukemia (ALL)].
Manabe A
Rinsho Ketsueki; 2013 Oct; 54(10):1999-2005. PubMed ID: 24064854
[No Abstract] [Full Text] [Related]
27. Gene variants offer clues to high-risk childhood ALL.
Jenks S
J Natl Cancer Inst; 2010 Dec; 102(23):1752-5. PubMed ID: 21088278
[No Abstract] [Full Text] [Related]
28. Recent advances in genetic predisposition to pediatric acute lymphoblastic leukemia.
Bloom M; Maciaszek JL; Clark ME; Pui CH; Nichols KE
Expert Rev Hematol; 2020 Jan; 13(1):55-70. PubMed ID: 31657974
[No Abstract] [Full Text] [Related]
29. MSH6 mutations and risk of uterine cancer.
Cancer Biol Ther; 2004 Jun; 3(6):491. PubMed ID: 15717409
[No Abstract] [Full Text] [Related]
30. Rare compound heterozygous mutations in gene
Ling C; Yang W; Sun H; Ge M; Ji Y; Han S; Zhang D; Zhang X
Clin Case Rep; 2018 Aug; 6(8):1448-1451. PubMed ID: 30147880
[TBL] [Abstract][Full Text] [Related]
31. Germline variation in cancer-susceptibility genes in a healthy, ancestrally diverse cohort: implications for individual genome sequencing.
Bodian DL; McCutcheon JN; Kothiyal P; Huddleston KC; Iyer RK; Vockley JG; Niederhuber JE
PLoS One; 2014; 9(4):e94554. PubMed ID: 24728327
[TBL] [Abstract][Full Text] [Related]
32. An isolated childhood myeloid sarcoma with germline MSH6 mutation-a case report.
Liu Y; GuLiBaHa M; Yue YB; Li MW; Cao SB; Yan M
Transl Pediatr; 2021 Aug; 10(8):2136-2143. PubMed ID: 34584885
[TBL] [Abstract][Full Text] [Related]
33. Compound Heterozygous Variants in Pediatric Cancers: A Systematic Review.
Miller DB; Piccolo SR
Front Genet; 2020; 11():493. PubMed ID: 32508881
[TBL] [Abstract][Full Text] [Related]
34. Novel Implications in Molecular Diagnosis of Lynch Syndrome.
Liccardo R; De Rosa M; Izzo P; Duraturo F
Gastroenterol Res Pract; 2017; 2017():2595098. PubMed ID: 28250766
[TBL] [Abstract][Full Text] [Related]
35. Genetic modifiers of neurofibromatosis type 1-associated café-au-lait macule count identified using multi-platform analysis.
Pemov A; Sung H; Hyland PL; Sloan JL; Ruppert SL; Baldwin AM; Boland JF; Bass SE; Lee HJ; Jones KM; Zhang X; ; Mullikin JC; Widemann BC; Wilson AF; Stewart DR
PLoS Genet; 2014 Oct; 10(10):e1004575. PubMed ID: 25329635
[TBL] [Abstract][Full Text] [Related]
36. Phenotype diversity in type 1 Gaucher disease: discovering the genetic basis of Gaucher disease/hematologic malignancy phenotype by individual genome analysis.
Lo SM; Choi M; Liu J; Jain D; Boot RG; Kallemeijn WW; Aerts JM; Pashankar F; Kupfer GM; Mane S; Lifton RP; Mistry PK
Blood; 2012 May; 119(20):4731-40. PubMed ID: 22493294
[TBL] [Abstract][Full Text] [Related]
37. Constitutional mismatch repair-deficiency syndrome.
Wimmer K; Kratz CP
Haematologica; 2010 May; 95(5):699-701. PubMed ID: 20442441
[No Abstract] [Full Text] [Related]
38. Compound heterozygosity for MSH6 mutations in a pediatric lymphoma patient.
Peters A; Born H; Ettinger R; Levonian P; Jedele KB
J Pediatr Hematol Oncol; 2009 Feb; 31(2):113-5. PubMed ID: 19194194
[TBL] [Abstract][Full Text] [Related]
39. Compound heterozygosity for two MSH6 mutations in a patient with early onset of HNPCC-associated cancers, but without hematological malignancy and brain tumor.
Plaschke J; Linnebacher M; Kloor M; Gebert J; Cremer FW; Tinschert S; Aust DE; von Knebel Doeberitz M; Schackert HK
Eur J Hum Genet; 2006 May; 14(5):561-6. PubMed ID: 16418736
[TBL] [Abstract][Full Text] [Related]
40. A lack of DNA mismatch repair on an athymic murine background predisposes to hematologic malignancy.
Campbell MR; Nation PN; Andrew SE
Cancer Res; 2005 Apr; 65(7):2626-35. PubMed ID: 15805259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
